EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 24 / No 5 (Mai 2008) Med Sci (Paris), 24 5 (2008) 470-472 References
Free Access
Issue
Med Sci (Paris)
Volume 24, Number 5, Mai 2008
Page(s) 470 - 472
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2008245470
Published online 15 May 2008
  1. Wrogemann K, Pena SD. Mitochondrial calcium overload: a general mechanism for cell-necrosis in muscle diseases. Lancet 1976; 1 : 672–4. [Google Scholar]
  2. Millay DP, Sargent MA, Osinska H, et al. Genetic and pharmacologic inhibition of mitochondrialdependent necrosis attenuates muscular dystrophy. Nat Med 2008; 14 : 442–7. [Google Scholar]
  3. Merlini L, Angelin A, Tiepolo T, et al. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 2008; 105 : 5225–9. [Google Scholar]
  4. Karpati G, Hilton-Jones D, Griggs R. Disorders of voluntary muscle, 7e ed. Cambridge : Cambridge University Press, 2001 : 776 p. [Google Scholar]
  5. Kaplan JC. The 2008 version of the gene table of neuromuscular disorders. Neuromuscul Disord 2008; 18 : 99–129. (http://194.167.35.195/). [Google Scholar]
  6. Allard B. Sarcolemmal ion channels in dystrophin-deficient skeletal muscle fibres. J Muscle Res Cell Motil 2006; 27 : 367–73. [Google Scholar]
  7. Constantin B, Sébille S, Cognard C. New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD. J Muscle Res Cell Motil 2006; 27 : 375–86. [Google Scholar]
  8. Ruegg UT, Nicolas-Metral V, Challet C, et al. Pharmacological control of cellular calcium handling in dystrophic skeletal muscle. Neuromuscul Disord 2002; 12 (suppl 1) : S155–61. [Google Scholar]
  9. Bernardi P, Colonna R, Costantini P, et al. The mitochondrial permeability transition. Biofactors 1998; 8 : 273–81. [Google Scholar]
  10. Bernardi P. Mitochondria in muscle cell death. Ital J Neurol Sci 1999; 20 : 395–400. [Google Scholar]
  11. Bernardi P, Krauskopf A, Basso E, et al. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 2006; 273 : 2077–99. [Google Scholar]
  12. Bernardi P, Rasola A. Calcium and cell death: the mitochondrial connection. Subcell Biochem 2007; 45 : 481–506. [Google Scholar]
  13. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 1999; 341 : 233–49. [Google Scholar]
  14. Halestrap AP. The mitochondrial permeability transition: its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 1999; 66 : 181–203. [Google Scholar]
  15. Halestrap A. Biochemistry: a pore way to die. Nature 2005; 434 : 578–9. [Google Scholar]
  16. Baines CP, Kaiser RA, Purcell NH, et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005; 434 : 658–62. [Google Scholar]
  17. Nakagawa T, Shimizu S, Watanabe T, et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005; 434 : 652–8. [Google Scholar]
  18. Waldmeier PC, Zimmermann K, Qian T, et al. Cyclophilin D as a drug target. Curr Med Chem 2003; 10 : 1485–506. [Google Scholar]
  19. Hansson MJ, Mattiasson G, Mansson R, et al. The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain derived mitochondria. J Bioenerg Biomembr 2004; 36 : 407–13. [Google Scholar]
  20. Bonaldo P, Braghetta P, Zanetti M, et al. Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. Hum Mol Genet 1998; 7 : 2135–40. [Google Scholar]
  21. Irwin WA, Bergamin N, Sabatelli P, et al. Mitochondrialdysfunction and apoptosis in myopathic mice with collagen VI deficiency. Nat Genet 2003; 35 : 367–71. [Google Scholar]
  22. Angelin A, Tiepolo T, Sabatelli P, et al. Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins. Proc Natl Acad Sci USA 2007; 104 : 991–6. [Google Scholar]
  23. Armstrong JS. Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 2007; 151 : 1154–65. [Google Scholar]
  24. Miller RG, Sharma KR, Pavlath GK, et al. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve 1997; 20 : 469–78. [Google Scholar]
  25. De Luca A, Nico B, Liantonio A, et al. A multidisciplinary evaluation of the effectiveness of cyclosporine A in dystrophic mdx mice. Am J Pathol 2005; 166 : 477–89. [Google Scholar]
  26. www.parentprojectmd.org/site/DocServer/interview_korinthenberg.pdf [Google Scholar]
  27. Stupka N, Gregorevic P, Plant DR, Lynch GS. The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Acta Neuropathol 2004; 107 : 299–310. [Google Scholar]
  28. Stupka N, Schertzer JD, Bassel-Duby R, et al. Stimulation of calcineurin A (alpha) activity attenuates muscle pathophysiology in mdx dystrophic mice. Am J Physiol Regul Integr Comp Physiol 2008; 294 : R983–92. [Google Scholar]
  29. St-Pierre SJ, Chakkalakal JV, Kolodziejczyk SM, et al. Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway. FASEB J 2004; 18 : 1937–9. [Google Scholar]
  30. Paeshuyse J, Kaul A, De Clercq E, et al. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro. Hepatology 2006; 43 : 761–70. [Google Scholar]
  31. Ptak RG, Gallay PA, Jochmans D, et al. Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother 2008; 52 : 1302–17. [Google Scholar]
  32. Teichgraber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008; 14 : 382–91. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.